Netherlands Heart Journal

, Volume 20, Issue 9, pp 347–353 | Cite as

Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial

  • A. Ghani
  • J-H. E. Dambrink
  • A. W. J. van ’t Hof
  • J. P. Ottervanger
  • A. T. M. Gosselink
  • J. C. A. Hoorntje
Original article

Abstract

Background

There are conflicting data regarding optimal treatment of non-culprit lesions detected during primary percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) and multi-vessel disease (MVD). We aimed to investigate whether ischaemia-driven early invasive treatment improves the long-term outcome and prevents major adverse cardiac events (MACE).

Methods

121 patients with at least one non-culprit lesion were randomised in a 2:1 manner, 80 were randomised to early fractional flow reserve (FFR)-guided PCI (invasive group), and 41 to medical treatment (conservative group). The primary endpoint was MACE at 3 years.

Results

Three-year follow-up was available in 119 patients (98.3 %). There was no significant difference in all-cause mortality between the invasive and conservative strategy, 4 patients (3.4 %) died, all in the invasive group (P = 0.29). Re-infarction occurred in 14 patients (11.8 %) in the invasive group versus none in the conservative group (p = 0.002). Re-PCI was performed in 7 patients (8.9 %) in the invasive group and in 13 patients (32.5 %) in the conservative group (P = 0.001). There was no difference in MACE between these two strategies (35.4 vs 35.0 %, p = 0.96).

Conclusions

In STEMI patients with MVD, early FFR-guided additional revascularisation of the non-culprit lesion did not reduce MACE at three-year follow-up compared with a more conservative strategy. The rate of MACE in the invasive group was predominantly driven by death and re-infarction, whereas in the conservative group the rate of MACE was only driven by repeat interventions.

Keywords

Acute myocardial infarction Multi-vessel disease Primary percutaneous coronary intervention Multi-vessel angioplasty Long-term follow-up Medical therapy 

Notes

Conflict of interest

No conflict of interest, no funding

References

  1. 1.
    Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and Mediterranean basin. The Euro Heart survey of acute coronary syndromes. Eur Heart J. 2002;23:1190–201.PubMedCrossRefGoogle Scholar
  2. 2.
    Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28:1709–16.PubMedCrossRefGoogle Scholar
  3. 3.
    Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915–22.PubMedCrossRefGoogle Scholar
  4. 4.
    Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European society of cardiology. Eur Heart J. 2003;24:28–66.PubMedCrossRefGoogle Scholar
  5. 5.
    Politi L, Sgura F, Rossi R, et al. A randomized trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart. 2010;96:662–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Serruys PW, Unger F, van Hout BA, et al. The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol. 1999;4:209–19.PubMedGoogle Scholar
  7. 7.
    Dambrink JHE, Debrauwere JP, van ’t Hof AWJ, et al. Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines? EuroIntervention. 2010;5:968–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010;3:22–31.PubMedCrossRefGoogle Scholar
  9. 9.
    Di Mario C, Mara S, Flavio A, et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent. 2004;6:128–33.PubMedGoogle Scholar
  10. 10.
    Biondi-Zoccai G, Lotrionte M, Sheiban I. Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty [Review]. Am Heart J. 2010;160:S28–35.PubMedCrossRefGoogle Scholar
  11. 11.
    Widimsky P, Holmes DR. How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J. 2011;32:396–403.PubMedCrossRefGoogle Scholar
  12. 12.
    Vlaar PJ, Mahmoud KD, Holmes DR, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2011;58:692–703.PubMedCrossRefGoogle Scholar
  13. 13.
    Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the european society of cardiology. Eur Heart J. 2005;26:804–47.PubMedCrossRefGoogle Scholar
  14. 14.
    Van der Schaaf RJ, Vis MM, Sjauw KD, et al. Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol. 2006;98:1165–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Media / Bohn Stafleu van Loghum 2012

Authors and Affiliations

  • A. Ghani
    • 1
  • J-H. E. Dambrink
    • 1
  • A. W. J. van ’t Hof
    • 1
  • J. P. Ottervanger
    • 1
  • A. T. M. Gosselink
    • 1
  • J. C. A. Hoorntje
    • 1
  1. 1.Department of CardiologyIsala kliniekenZwollethe Netherlands

Personalised recommendations